logo

For the Inventor, By the Inventor

Wadsworth, IL, United States of America

Irene I Drizin

This inventor holds 27 USPTO granted patents and 1 published patent application, plus 1 CIPO patent, primarily in Calcium Channel Blockers. Top assignees: Abbott Laboratories Corporation, Abbvie Inc., Abbott Gmbh & Co Kg. Active years: 1996-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irene I Drizin. Retrieved from https://idiyas.com/inventor/irene-i-drizin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 

% Patents Active = 66.7

 

Average Co-Inventor Count = 6.3

ph-index = 11

Forward Citations = 286(Granted Patents)


Location History:

  • Waukegan, IL (US) (1996)
  • Wadsworth, IL (US) (1997 - 2014)

Company Filing History:

goldMedal22 out of 4,187 
 
Abbott Laboratories Corporation
 patents
silverMedal4 out of 826 
 
Abbvie Inc.
 patents
bronzeMedal1 out of 140 
 
Abbott Gmbh & Co Kg
 patents
4. 1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1996-2014

Loading Chart...
Loading Chart...
Areas of Expertise:
Calcium Channel Blockers
TRPV1 Antagonists
Pyrimidine Derivatives
Fused Azabicyclic Compounds
Potassium Channel Openers
Dihydropyrazolone
Dihydropyrimidine
Hexahydrobenz Isoindole
Benzopyranopyrrole
Amino Heterocyclic
Macrocyclic Compounds
Pain Treatment
27 patents (USPTO):Explore Patents
1. 8859584 - TRPV1 antagonists (2014-10-14),
2. 8815869 - Lactam acetamides as calcium channel blockers (2014-08-26),
3. 8735411 - Macrocyclic benzofused pyrimidine derivatives (2014-05-27),
4. 8546410 - Heteroaryl-fused macrocyclic pyrimidine derivatives (2013-10-01),
5. 8436005 - Macrocyclic pyrimidine derivatives (2013-05-07),
6. 8278311 - Substituted pyrimidine derivatives (2012-10-02),
7. 8268846 - Amino heterocyclic linked pyrimidine derivatives (2012-09-18),
8. 8247413 - Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor (2012-08-21),
9. 8044069 - Compounds as calcium channel blockers (2011-10-25),
10. 7985745 - Method for pain treatment (2011-07-26),
11. 7335678 - Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1(VR1) receptor (2008-02-26),
12. 7074805 - Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor (2006-07-11),
13. 6933311 - Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor (2005-08-23),
14. 6780872 - Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers (2004-08-24),
15. 6642222 - Pyrano, piperidino, and thiopyrano compounds and methods of use (2003-11-04),

Title: Innovations and Achievements of Irene I Drizin

Introduction

Irene I Drizin, located in Wadsworth, IL, is an accomplished inventor with a significant portfolio of 27 patents to her name. Her work has contributed to advancements in various fields, particularly in the development of therapeutic compounds.

Latest Patents

Among her latest patents, Irene has disclosed new compounds known as TRPV1 antagonists, which include compositions for treating various conditions and disorders using specific formulations. Another notable patent involves lactam acetamides as calcium channel blockers, showcasing her innovative contributions to medicine through detailed formulations and methods of treatment.

Career Highlights

Irene has had a notable career, working for prestigious companies like Abbott Laboratories Corporation and AbbVie Inc. Her extensive experience in research and development has allowed her to make substantial contributions to the pharmaceutical industry, particularly in drug discovery and formulation.

Collaborations

Throughout her career, Irene has collaborated with esteemed colleagues, including Robert J Altenbach and William A Carroll. These partnerships have fostered innovation and have been instrumental in the progression of her projects and patents.

Conclusion

Irene I Drizin stands out as a remarkable inventor with a rich background in medicine and pharmaceutical development. Her 27 patents reflect her commitment to innovation and her impact on improving therapeutic options for various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…